Literature DB >> 16570438

[Observation on therapeutic effect of rolling needle therapy on insomnia].

Ling Luo1, You-ping Hu, Shu-guang Yu, Ning Li.   

Abstract

OBJECTIVE: To assess the effect-increasing action of rolling needle therapy on insomnia.
METHODS: Sixty-four cases were randomly divided into a rolling needle treatment group and a control group, 32 cases in each group. The control group were treated with oral administration of clonazepam 4 mg, once each night, for 4 consecutive weeks. The rolling needle therapy group were treated with the same treatment as the control group, plus the rolling needle stimulation of the back. The therapeutic effect was assessed by effective rate of sleep improvement and Pittsburgh sleep quality index (PSQI).
RESULTS: After treatment there was a significant difference between the two groups in the score of PSQI (P < 0.01).
CONCLUSION: The rolling needle therapy can increase the improving action of clonazepam on insomnia, and increase life quality of the patient.

Entities:  

Mesh:

Year:  2006        PMID: 16570438

Source DB:  PubMed          Journal:  Zhongguo Zhen Jiu        ISSN: 0255-2930


  3 in total

Review 1.  Acupuncture for treatment of insomnia: a systematic review of randomized controlled trials.

Authors:  Huijuan Cao; Xingfang Pan; Hua Li; Jianping Liu
Journal:  J Altern Complement Med       Date:  2009-11       Impact factor: 2.579

2.  Crossbow needle therapy of the Miao ethnic minority group for knee osteoarthritis: study protocol for a randomized controlled trial.

Authors:  Jing Fu; Hong-Cai Shang; Li-Ying Wang; Chen Zhao; Jin Cui; Yan-Ping Wang
Journal:  Trials       Date:  2018-06-27       Impact factor: 2.279

Review 3.  Efficacy Comparison of Different Acupuncture Treatments for Primary Insomnia: A Bayesian Analysis.

Authors:  Huachong Xu; Yucong Shi; Yike Xiao; Pei Liu; Sizhi Wu; Peng Pang; Li Deng; Xiaoyin Chen
Journal:  Evid Based Complement Alternat Med       Date:  2019-09-03       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.